Whereas early acute cellular rejection, even if successfully treated, seems
to have an impact on late function and survival of kidney and heart transp
lants, little quantitative data are available on its effect(s) on liver tra
nsplants. Routine liver function tests, the functioning liver cell mass (ga
lactose elimination capacity) and microsomal metabolic capacity (aminopyrin
e breath test) were determined prospectively in 37 consecutive patients 1 y
ear after liver transplantation. Of these, 19 (7 females and 12 males, 32-6
9 years of age) had previously required treatment for at least one biopsy p
roven acute cellular rejection episode occuring a median 7 days after graft
ing, while 18 (6 females and 12 males, 30-67 years of age) had not. The fun
ctioning liver cell mass and microsomal metabolic capacity were both within
normal limits for the majority of patients and did not differ significantl
y between patients with and without previous acute cellular rejection episo
des. In contrast to other solid organ transplants, early acute cellular rej
ection episodes do not affect late function of liver allografts in man.